Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

110 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The genetic determinants of the CYP3A5 polymorphism.
Hustert E, Haberl M, Burk O, Wolbold R, He YQ, Klein K, Nuessler AC, Neuhaus P, Klattig J, Eiselt R, Koch I, Zibat A, Brockmöller J, Halpert JR, Zanger UM, Wojnowski L. Hustert E, et al. Among authors: wojnowski l. Pharmacogenetics. 2001 Dec;11(9):773-9. doi: 10.1097/00008571-200112000-00005. Pharmacogenetics. 2001. PMID: 11740341
Clinical implications of CYP3A polymorphisms.
Wojnowski L, Kamdem LK. Wojnowski L, et al. Expert Opin Drug Metab Toxicol. 2006 Apr;2(2):171-82. doi: 10.1517/17425255.2.2.171. Expert Opin Drug Metab Toxicol. 2006. PMID: 16866606 Review.
CYP3 phylogenomics: evidence for positive selection of CYP3A4 and CYP3A7.
Qiu H, Taudien S, Herlyn H, Schmitz J, Zhou Y, Chen G, Roberto R, Rocchi M, Platzer M, Wojnowski L. Qiu H, et al. Among authors: wojnowski l. Pharmacogenet Genomics. 2008 Jan;18(1):53-66. doi: 10.1097/FPC.0b013e3282f313f8. Pharmacogenet Genomics. 2008. PMID: 18216722
Three haplotypes associated with CYP2A6 phenotypes in Caucasians.
Haberl M, Anwald B, Klein K, Weil R, Fuss C, Gepdiremen A, Zanger UM, Meyer UA, Wojnowski L. Haberl M, et al. Among authors: wojnowski l. Pharmacogenet Genomics. 2005 Sep;15(9):609-24. doi: 10.1097/01.fpc.0000171517.22258.f1. Pharmacogenet Genomics. 2005. PMID: 16041240
Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.
Niemi M, Arnold KA, Backman JT, Pasanen MK, Gödtel-Armbrust U, Wojnowski L, Zanger UM, Neuvonen PJ, Eichelbaum M, Kivistö KT, Lang T. Niemi M, et al. Among authors: wojnowski l. Pharmacogenet Genomics. 2006 Nov;16(11):801-8. doi: 10.1097/01.fpc.0000230422.50962.91. Pharmacogenet Genomics. 2006. PMID: 17047488
Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus.
Kamdem LK, Streit F, Zanger UM, Brockmöller J, Oellerich M, Armstrong VW, Wojnowski L. Kamdem LK, et al. Among authors: wojnowski l. Clin Chem. 2005 Aug;51(8):1374-81. doi: 10.1373/clinchem.2005.050047. Epub 2005 Jun 10. Clin Chem. 2005. PMID: 15951320
110 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page